Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The Duchenne Registry is an online program designed to support individuals with Duchenne and Becker muscular dystrophy, as well as their families. The main goal of the Registry is to connect patients with clinical trials and research studies that are currently looking for participants. It also provides important information about care and research related to these conditions. By joining the Registry, patients and their families can help researchers by sharing valuable health information, which is essential for improving treatments and care for Duchenne and Becker muscular dystrophy.
To be eligible for the Duchenne Registry, participants need to have a diagnosis of Duchenne or Becker muscular dystrophy. This includes both women who show symptoms and those who do not, as well as female carriers of the disease. However, individuals with other types of muscular dystrophy are not eligible. By joining, participants can expect to be part of a community that helps advance research and treatment options for these conditions. The Registry is open to people of all ages and genders, making it a welcoming resource for anyone affected by these muscular disorders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Duchenne or Becker muscular dystrophy; Manifesting female carriers and asymptomatic female carriers also included in registry.
- Exclusion Criteria:
- • Diagnosis of any other type of muscular dystrophy (including limb-girdle muscular dystrophy).
About The Duchenne Registry
The Duchenne Registry is a leading clinical trial sponsor dedicated to advancing research and improving outcomes for individuals affected by Duchenne muscular dystrophy (DMD). By facilitating the collection and analysis of comprehensive patient data, the registry aims to enhance understanding of DMD's natural history, treatment responses, and long-term effects. Collaborating with healthcare providers, researchers, and families, the Duchenne Registry fosters a robust network that promotes innovative therapeutic strategies and drives the development of targeted interventions, ultimately striving to enhance the quality of life for those living with DMD.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Washington, District Of Columbia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials